Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

The new insulin, Awiqli, is cheaper than many daily insulin analogues and could ease fears of multiple injections among ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like its reference ...

Designed to reduce daily insulin injections to a single weekly dose, the long-acting insulin aims to improve treatment ...